Overview of Global Pulmonary Drug Delivery Devices Market
Pulmonary drug delivery systems refer to
technologies that are used to treat diseases such as asthma, chronic
obstructive pulmonary disease (COPD), and cystic fibrosis
using pulmonary route of drug administration. These systems have been in
medical use for more than six decades. However, recent technological
advancements in pulmonary drug delivery systems have expanded their potential
application in other diseases such as diabetes, lung cancer, and others.
The pulmonary drug delivery market deals with
devices that help with the inhalation of drug formulation through mouth and
further deposition of inhaled pharmacological agent in lower airways. The rise
in prevalence of major respiratory problems such as COPD, asthma, and cystic
fibrosis is a major factor driving the global pulmonary drug delivery devices
market.
Request
a Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=48993
The global pulmonary drug delivery devices market
has been segmented on the basis of product type, application, and distribution
channel. In terms of product type, the global pulmonary drug delivery devices
market has been classified into dry powder
inhalers, metered dose inhalers, and nebulizers. Based on
application, the global pulmonary drug delivery devices market has been
categorized into asthma, COPD, cystic fibrosis, and
others.
In terms of distribution channel, the global
pulmonary drug delivery devices market has been divided into retail pharmacies,
hospital pharmacies, and e-commerce.
Increase
in Prevalence and Incidence of Respiratory Diseases to Drive Global Market
The surge in trend of pulmonary drug delivery due
to large absorptive area, thin absorptive mucosal membrane, and efficient blood
supply is likely to propel the global pulmonary drug delivery devices market.
The growing need of minimal invasive and effective treatment, and rise in the
number of people with habit of smoking are projected to fuel the growth of the
global pulmonary drug delivery devices market.
Moreover, increase in incidence of chronic
respiratory diseases is projected to drive the demand for pulmonary drug
delivery systems (PDDS) in the near future. According to data published by the
Global Asthma Network (GAN) in “The Global Asthma Report 2014”, asthma affects
around 334 million people globally. Rise in prevalence and incidence of
respiratory diseases has led to an increase in the patient population, which in
turn has fueled the demand for these systems. This consequent increase in
demand is likely to propel the global market in the next few years.
Request
For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=48993
Surge
in Number of Initiatives Undertaken by Government and Non-Government
Organizations
Rise in the number of initiatives undertaken by
government and non-government organizations drives the global pulmonary drug
delivery devices market, in terms of revenue. For instance, the CDC’s National
Asthma Control Program (NACP) provides funds for educating asthma affected
patients. Such initiatives are likely to increase awareness about asthma, which
will drive the adoption of PDDS in the treatment of chronic obstructive
pulmonary disease (COPD) and asthma.
High
Adoption Rate of Metered Dose Inhalers for Effective Inhalation Therapy for
Asthma
In terms of product type, the global pulmonary drug
delivery devices market has been classified into dry powder inhalers, metered
dose inhalers, and nebulizers. The metered dose inhalers (MDI) segment held key
market share in 2020. Presence of major players involved in the development of
novel MDIs and high acceptance rate of these devices in developing regions,
such as Asia Pacific and Latin America, are the major factors propelling the
segment.
Based on application, the global pulmonary drug
delivery devices market has been categorized into asthma, COPD, cystic
fibrosis, and others. The asthma segment held key share of the global market in
2020. An effective inhalation therapy that uses DPIs and MDIs is considered the
basis of asthma management. The demand and usage of devices such as MDIs and DPIs
for asthma management are increasing due to high number of people affected by
asthma, which in turn fuels the growth of the asthma segment.
Enquiry
Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=48993
Rise
in Hospitalizations to Fuel Growth of Global Pulmonary Drug Delivery Devices
Market
Based on distribution channel, the global pulmonary
drug delivery devices market has been categorized into retail pharmacies,
hospital pharmacies, and e-commerce. The hospital pharmacies segment held
notable share of the global pulmonary drug delivery devices market in 2021, and
the trend is projected to continue in the near future. Hospitals offer
extensive treatments, care, quick reimbursements, and insurance policies due to
which patients prefer hospital pharmacies. Moreover, increase in the number of
hospitalizations is anticipated to fuel the growth of the segment.
Request
Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=48993
Regional
Outlook of Global Pulmonary Drug Delivery Devices Market
In terms of region, the global pulmonary drug
delivery devices market has been segmented into North America, Europe, Asia
Pacific, Latin America, and Middle East & Africa. North America dominated
the global pulmonary drug delivery devices market in 2021, followed by Europe.
This can be attributed to the increase in incidence of diseases such as COPD
and asthma. Rise in the number of patients affected by these diseases increases
the demand for diagnostic devices, including PDDS, thereby propelling the
market in the region.
Analysis
of Key Players in Global Pulmonary Drug Delivery Devices Market
This report by Transparency Market Research
profiles key players in the global pulmonary drug delivery devices market based
on various attributes such as company overview, financial overview, product
portfolio, business strategies, and recent developments. The global pulmonary
drug delivery devices market is highly fragmented, with the presence of a
number of international as well as regional players.
Leading players operating in the global pulmonary
drug delivery devices market are Boehringer Ingelheim GmbH, Novartis AG,
GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., AstraZeneca plc,
Merck & Co., Inc., MannKind Corporation, F. Hoffmann-La Roche Ltd.,
Bristol-Myers Squibb Company, Mylan N.V., Omron Corporation, 3M Healthcare,
Sunovion Pharmaceuticals, Inc., Koninklijke Philips N.V., Gerresheimer AG,
Bespak, AptarGroup, Inc., SHL Group, Nypro Healthcare, Inc. (Jabil Circuit,
Inc.), Hovione, and Chiesi Farmaceutici S.p.A., among others.
Ask
References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=48993
Key
Developments in Global Pulmonary Drug Delivery Devices Market
The market is quite competitive, with key players
engaged in mergers & acquisitions, new product development, collaborations
& partnerships, and growth strategies to increase market penetration. Rise
in the number of companies is expected to fuel competition in the near future.
Hence, competitive rivalry in the respiratory market is expected to be high
during the forecast period. Additionally, these players offer services that are
aimed at enhancing the quality of drug delivery systems and better patient
care. Moreover, the need of more efficient systems and competition among new
entrants are anticipated to augment the global pulmonary drug delivery devices
market in the next few years. Strategies adopted by players operating in the
global pulmonary drug delivery devices market include:
- In May 2017, Koninklijke Philips
N.V. entered into a definitive agreement to acquire Respiratory
Technologies, Inc. (RespirTech) in order to expand its respiratory care
product portfolio
More Trending Reports by Transparency Market Research:
Optical Lens Edger Market - https://www.transparencymarketresearch.com/optical-lens-edger-market.html
Bladder Scanners Market - https://www.transparencymarketresearch.com/bladder-scanner-market.html
Label-free Array Systems Market - https://www.transparencymarketresearch.com/label-free-array-systems-market.html
Diagnostic Imaging Services Market - https://www.transparencymarketresearch.com/diagnostic-imaging-services-market.html
Shoulder Replacement Market - https://www.transparencymarketresearch.com/shoulder-replacement-market.html
Canes and Crutches Market - https://www.transparencymarketresearch.com/canes-crutches-market.html
Motion Preservation Devices Market - https://www.transparencymarketresearch.com/motion-preservation-devices-market.html
Endoscope Washer Disinfector Market - https://www.transparencymarketresearch.com/endoscope-washerdisinfectors-market.html
About Us
Transparency
Market Research, a global market research company registered at Wilmington,
Delaware, United States, provides custom research and consulting services. The
firm scrutinizes factors shaping the dynamics of demand in various
markets. The insights and perspectives on the markets evaluate
opportunities in various segments. The opportunities in the segments based on
source, application, demographics, sales channel, and end-use are analysed,
which will determine growth in the markets over the next decade.
Our
exclusive blend of quantitative forecasting and trends analysis provides forward-looking
insights for thousands of decision-makers, made possible by experienced teams
of Analysts, Researchers, and Consultants. The proprietary data sources and
various tools & techniques we use always reflect the latest trends and
information. With a broad research and analysis capability, Transparency Market
Research employs rigorous primary and secondary research techniques in all of
its business reports.
For More Research Insights on Leading Industries, Visit Our
YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
No comments:
Post a Comment